檢索結果 - Jan Dürig

Refine Results
  1. 1
    HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

    HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia 由 Holger Nückel, Vera Rebmann, Jan Dürig, Ulrich Dührsen, Hans Grosse‐Wilde

    出版 2004
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells

    CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells 由 Silvia Deaglio, Andrea Capobianco, L Bergui, Jan Dürig, Fortunato Morabito, Ulrich Dührsen, Fabio Malavasi

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Cellular origin and pathophysiology of chronic lymphocytic leukemia

    Cellular origin and pathophysiology of chronic lymphocytic leukemia 由 Marc Seifert, Ludger Sellmann, Johannes Bloehdorn, Frederik Wein, Stephan Stilgenbauer, Jan Dürig, Ralf Küppers

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Revision of the Human Hematopoietic Tree: Granulocyte Subtypes Derive from Distinct Hematopoietic Lineages

    Revision of the Human Hematopoietic Tree: Granulocyte Subtypes Derive from Distinct Hematopoietic Lineages 由 André Görgens, Stefan Radtke, Michael Möllmann, Michael Cross, Jan Dürig, Peter A. Horn, Bernd Giebel

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia

    CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia 由 Jan Dürig, M Naschar, U Schmücker, K. Renzing‐Köhler, Tanja Hölter, Andreas Hüttmann, Ulrich Dührsen

    出版 2002
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells

    Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells 由 Stavros Manteniotis, Sebastian Wojcik, Joachim R. Göthert, Jan Dürig, Ulrich Dührsen, Günter Gisselmann, Hanns Hatt

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway

    Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway 由 René Handrick, Teona Ontikatze, Kerstin-Daniela Bauer, Florian Freier, Amelie Rübel, Jan Dürig, Claus Belka, Verena Jendrossek

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Multipotent Hematopoietic Progenitors Divide Asymmetrically to Create Progenitors of the Lymphomyeloid and Erythromyeloid Lineages

    Multipotent Hematopoietic Progenitors Divide Asymmetrically to Create Progenitors of the Lymphomyeloid and Erythromyeloid Lineages 由 André Görgens, Anna‐Kristin Ludwig, Michael Möllmann, Adalbert Krawczyk, Jan Dürig, Helmut Hanenberg, Peter A. Horn, Bernd Giebel

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Association of a novel regulatory polymorphism (−938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia

    Association of a novel regulatory polymorphism (−938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia 由 Holger Nückel, Ulrich H. Frey, Maja Bau, Ludger Sellmann, Jens Stanelle, Jan Dürig, Karl‐Heinz Jöckel, Ulrich Dührsen, Winfried Siffert

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia

    Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia 由 Maher Hanoun, Lewin Eisele, Masako Suzuki, John M. Greally, Andreas Hüttmann, Semra Aydin, René Scholtysik, Ludger Klein‐Hitpaß, Ulrich Dührsen, Jan Dürig

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Recurrent mutations in NF-κB pathway components, <i>KMT2D,</i> and <i>NOTCH1/2</i> in ocular adnexal MALT-type marginal zone lymphomas

    Recurrent mutations in NF-κB pathway components, <i>KMT2D,</i> and <i>NOTCH1/2</i> in ocular adnexal MALT-type marginal zone lymphomas 由 Patricia Johansson, Ludger Klein‐Hitpaß, Florian Grabellus, Georg J. Arnold, Wolfram Klapper, Roman Pförtner, Ulrich Dührsen, Anja Eckstein, Jan Dürig, Ralf Küppers

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    <scp>HLA‐E</scp> allelic genotype correlates with <scp>HLA‐E</scp> plasma levels and predicts early progression in chronic lymphocytic leukemia

    <scp>HLA‐E</scp> allelic genotype correlates with <scp>HLA‐E</scp> plasma levels and predicts early progression in chronic lymphocytic leukemia 由 Bettina Wagner, Fabiola da Silva Nardi, Sabine Schramm, Thomas Kraemer, Alexander A. Celik, Jan Dürig, Peter A. Horn, Ulrich Dührsen, Holger Nückel, Vera Rebmann

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    A Novel Nonobese Diabetic/Severe Combined Immunodeficient Xenograft Model for Chronic Lymphocytic Leukemia Reflects Important Clinical Characteristics of the Disease

    A Novel Nonobese Diabetic/Severe Combined Immunodeficient Xenograft Model for Chronic Lymphocytic Leukemia Reflects Important Clinical Characteristics of the Disease 由 Jan Dürig, Peter R. Ebeling, Florian Grabellus, Ursula R. Sorg, Michael Möllmann, Philipp Schütt, Joachim R. Göthert, Ludger Sellmann, S. Seeber, Michael Flaßhove, Ulrich Dührsen, Thomas Moritz

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    miR-34a as part of the resistance network in chronic lymphocytic leukemia

    miR-34a as part of the resistance network in chronic lymphocytic leukemia 由 Thorsten Zenz, Julia Mohr, Eric Eldering, Arnon P. Kater, Andreas Bühler, Dirk Kienle, Dirk Winkler, Jan Dürig, Marinus H. J. van Oers, Daniel Mertens, Hartmut Döhner, Stephan Stilgenbauer

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia

    Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia 由 Jan Dürig, Holger Nückel, Andreas Hüttmann, Elisabeth Kruse, Tanja Hölter, Katja Halfmeyer, Anja Führer, R. Rudolph, Naser Kalhori, Arnd Nusch, Silvia Deaglio, Fabio Malavasi, Tarik Möröy, Ludger Klein‐Hitpaß, Ulrich Dührsen

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia

    SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia 由 Patricia Johansson, Ludger Klein‐Hitpaß, Axel Choidas, Peter Habenberger, Bijan Mahboubi, Baek Kim, Anke K. Bergmann, René Scholtysik, Martina Brauser, Anna Lollies, Reiner Siebert, Thorsten Zenz, Ulrich Dührsen, Ralf Küppers, Jan Dürig

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Poor efficacy and tolerability of <scp>R‐CHOP</scp> in relapsed/refractory chronic lymphocytic leukemia and <scp>R</scp>ichter transformation

    Poor efficacy and tolerability of <scp>R‐CHOP</scp> in relapsed/refractory chronic lymphocytic leukemia and <scp>R</scp>ichter transformation 由 Petra Langerbeins, Raymonde Busch, Nadine Anheier, Jan Dürig, Michael Bergmann, Maria‐Elisabeth Goebeler, Hans‐Jürgen Hurtz, Martina Stauch, Stephan Stilgenbauer, Hartmut Döhner, Anna‐Maria Fink, Paula Cramer, Kirsten Fischer, Clemens‐Martin Wendtner, Michael Hallek, Barbara Eichhorst

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Two Years Rituximab Maintenance Vs. Observation after First Line Treatment with Bendamustine Plus Rituximab (B-R) in Patients with Waldenström's Macroglobulinemia (MW): Results of a Prospective, Randomized, Multicenter Phase 3 Study (the StiL NHL7-2008 MAINTAIN trial)

    Two Years Rituximab Maintenance Vs. Observation after First Line Treatment with Bendamustine Plus Rituximab (B-R) in Patients with Waldenström's Macroglobulinemia (MW): Results of... 由 Mathias Rummel, Christian Lerchenmüller, Manfred Hensel, Martin Göerner, Christian Buske, H. Schulz, Burkhard Schmidt, G. Kojouharoff, Elisabeth Lange, Wolfgang Willenbacher, Jan Dürig, Erik Engel, Frank Kauff, Jürgen Barth, Alexander Burchardt, Axel Hinke, Jasmin Wupperfeld, Richard Greil

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL

    JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL 由 Linus Wahnschaffe, Till Braun, Sanna Timonen, Anil K. Giri, Alexandra Schrader, Prerana Wagle, Henrikki Almusa, Patricia Johansson, Dorine Bellanger, Cristina López, Claudia Haferlach, Marc‐Henri Stern, Jan Dürig, Reiner Siebert, Satu Mustjoki, Tero Aittokallio, Marco Herling

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Genes encoding members of the <scp>JAK</scp>‐<scp>STAT</scp> pathway or epigenetic regulators are recurrently mutated in T‐cell prolymphocytic leukaemia

    Genes encoding members of the <scp>JAK</scp>‐<scp>STAT</scp> pathway or epigenetic regulators are recurrently mutated in T‐cell prolymphocytic leukaemia 由 Cristina López, Anke K. Bergmann, Ulrike Paul, Eva Maria Murga Penas, Inga Nagel, Matthew J. Betts, Patricia Johansson, Matthias Ritgen, Tycho Baumann, Marta Aymerich, Sandrine Jayne, Robert B. Russell, Elı́as Campo, Martin J.S. Dyer, Jan Dürig, Reiner Siebert

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: